These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7408401)

  • 21. The simultaneous determination of propoxyphene and norpropoxyphene in human biofluids using gas-liquid chromatography.
    Verebely K; Inturrisi CE
    J Chromatogr; 1973 Jan; 75(2):195-205. PubMed ID: 4701539
    [No Abstract]   [Full Text] [Related]  

  • 22. A high propoxyphene concentration.
    Eberhardt RD; Cash DK; Oehldrich JR
    J Anal Toxicol; 1984; 8(5):246-7. PubMed ID: 6503231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of propoxyphene and its major metabolites in heroin addict plasma after large dose administration of propoxyphene napsylate.
    Nash JF; Bennett IF; Bopp RJ; Brunson MK; Sullivan HR
    J Pharm Sci; 1975 Mar; 64(3):429-33. PubMed ID: 1151627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male Wistar rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Arch Toxicol; 1985 Jan; 56(3):170-4. PubMed ID: 3977596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol does not increase lethality due to propoxyphene in rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Alcohol; 1985; 2(2):293-6. PubMed ID: 4015849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.
    Nickander R; Smits SE; Steinberg MI
    J Pharmacol Exp Ther; 1977 Jan; 200(1):245-53. PubMed ID: 13200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk.
    Kunka RL; Yong CL; Ladik CF; Bates TR
    J Pharm Sci; 1985 Jan; 74(1):103-4. PubMed ID: 3981406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous quantitation of meperidine, normeperidine, tramadol, propoxyphene and norpropoxyphene in human plasma using solid-phase extraction and gas chromatography/mass spectrometry: Method validation and application to cardiovascular safety of therapeutic doses.
    Fernández N; Olivera NM; Keller GA; Diez RA; Di Girolamo G; Quiroga PN
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1519-1533. PubMed ID: 28686794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of propoxyphene and propranolol in children.
    Wilson JT; Atwood GF; Shand DG
    Clin Pharmacol Ther; 1976 Mar; 19(3):264-70. PubMed ID: 1261164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased absorption of propoxyphene by activated charcoal.
    Glab WN; Corby DG; Decker WJ; Coldiron VR
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):129-38. PubMed ID: 6125599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of propoxyphene and norpropoxyphene in man after a single oral dose.
    Verebely K; Inturrisi CE
    Clin Pharmacol Ther; 1974 Mar; 15(3):302-9. PubMed ID: 4815955
    [No Abstract]   [Full Text] [Related]  

  • 34. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propoxyphene bioavailability: an evaluation of ten products.
    Slywka GW; Melikian AP; Whyatt PL; Meyer MC
    J Clin Pharmacol; 1975; 15(8-9):598-604. PubMed ID: 1150913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro metabolism of propoxyphene in rat liver: reaction of a carbinol metabolite with acetaldehyde.
    Hermansson I; Hermansson J; Stjernström NE
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):257-64. PubMed ID: 6650176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of plasma levels of propoxyphene and norpropoxyphene by combined use of stable isotope labeling and selected ion monitoring.
    Sullivan HR; Emmerson JL; Marshall FK; Wood PG; McMahon RE
    Drug Metab Dispos; 1974; 2(6):526-32. PubMed ID: 4155676
    [No Abstract]   [Full Text] [Related]  

  • 38. Entrance into brain of dextropropoxyphene and the toxic metabolite norpropoxyphene.
    Way WL; Schou J
    Arch Toxicol Suppl; 1979; (2):367-70. PubMed ID: 288347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interaction of propoxyphene with ethanol.
    Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL
    Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excretion of propoxyphene and norpropoxyphene in breast milk.
    Kunka RL; Venkataramanan R; Stern RM; Ladik CF
    Clin Pharmacol Ther; 1984 May; 35(5):675-80. PubMed ID: 6713779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.